On March 8, 2023, the U.S. Food and Drug Administration (FDA) released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. On the same day, the agency’s response to the recent infant formula safety and supply crisis was called into question during a hearing with the U.S. House of Representatives Subcommittee on Health Care and Financial Services Hearing.
The U.S. Food and Drug Administration (FDA) has completed its second premarket consultation for a food made from cultured animal cells intended for human consumption. FDA evaluated the information submitted by GOOD Meat Inc. and has no further questions at this time about the company’s safety conclusion.
On March 17, 2023, two bipartisan pieces of legislation were introduced to the U.S. House of Representatives with the goal of requiring the U.S. Food and Drug Administration (FDA) to regulate cannabidiol (CBD) products in foods and dietary supplements.
The U.S. Food and Drug Administration (FDA) has released a report, titled, Activities for the Safety of Imported Seafood. The document shares the steps that FDA is taking to ensure that seafood imported to the U.S. meets food safety requirements and the standards of domestically produced seafood.
The U.S. Food and Drug Administration (FDA) will release a new prevention strategy aimed at reducing foodborne listeriosis cases and outbreaks associated with the consumption of fresh, soft Queso Fresco-type (QFT) cheeses.
The U.S. Food and Drug Administration (FDA) has announced it is requesting $7.2 billion as part of the president’s fiscal year (FY) 2024 budget, $128.2 million of which the agency intends to invest in food safety and nutrition modernization, including food labeling and animal food safety oversight. The agency also announced a number of legislative proposals that enhance its regulatory authorities alongside the funding requests.
In a letter, top U.S. Food and Drug Administration (FDA) officials called upon the infant formula industry to help the agency in protecting infants by ensuring the safety of their products.
The U.S. Food and Drug Administration (FDA) held a webinar to provide an overview of recently established action levels for lead in food intended for babies and children, as well as to answer stakeholder questions. The action levels were set out in a draft guidance, titled, Action Levels for Lead in Food Intended for Babies and Young Children, in January 2023, in support of FDA’s Closer to Zero initiative.
The U.S. Food and Drug Administration (FDA) has announced a national search for a new Deputy Commissioner for Human Foods and provided an update on the recently proposed restructuring of the agency's Human Foods Program and Office of Regulatory Affairs. Following the announcement, organizations representing consumers, industry, and state and local regulators expressed their concerns.
The U.S. Food and Drug Administration (FDA) has announced the withdrawal of the 2005 proposed rule, titled, Food Standards; General Principles and Food Standards Modernization, which was published jointly with the U.S. Department of Agriculture (USDA) to establish a set of general principles for FDA and FSIS to use when considering whether to establish, revise, or eliminate a food standard.
